Safety labeling on generic drugs is inconsistent, study says

BMJ 2012; 345 doi: http://dx.doi.org/10.1136/bmj.e8650 (Published 21 December 2012)
Cite this as: BMJ 2012;345:e8650

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Bob Roehr
  1. 1Washington, DC

Generic drugs are required by US law to carry safety warnings on their labels identical to those on the branded drugs, but a new study shows that 68% of the time there were inconsistencies between the two.1

The study used software to extract and compare electronic versions of all package inserts in the Food and Drug Administration’s DailyMed repository, a total of 9105 product labels as at September 2010, representing …

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

THIS WEEK'S POLL